搜索文档
Floor & Decor(FND) - 2026 Q1 - Quarterly Report
2026-05-01 04:18
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________ FORM 10-Q _________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 26, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number 001-38070 _____________________ ...
Amazon (NASDAQ: AMZN) Sees Price Target Hikes Following Robust Earnings Report
Financial Modeling Prep· 2026-05-01 04:17
Amazon.com Inc. (NASDAQ: AMZN) is a global technology company primarily focused on e-commerce, cloud computing, and digital streaming. As an e-commerce giant and cloud computing leader, with a massive market capitalization of approximately $2.78 trillion, it is one of the world's most valuable companies. Its Amazon Web Services (AWS) division is a leader in the cloud infrastructure market. On April 30, 2026, an analyst from Scotiabank raised their price target for Amazon to $325.00 from a previous target of ...
AIG(AIG) - 2026 Q1 - Quarterly Results
2026-05-01 04:17
Press Release Contacts: www.aig.com Quentin McMillan (Investors): quentin.mcmillan@aig.com Andrew Johnson (Media): andrew.r.johnson@aig.com AIG Reports Excellent First Quarter 2026 Results NEW YORK, April 30, 2026 – American International Group, Inc. (NYSE: AIG) today reported financial results for the first quarter ended March 31, 2026. "AIG entered 2026 with significant momentum and delivered outstanding first quarter results, highlighting the strength of our underwriting capabilities and sustained earnin ...
Bio-Rad(BIO) - 2026 Q1 - Quarterly Results
2026-05-01 04:17
Exhibit 99.1 Press Release Bio-Rad Reports First-Quarter 2026 Financial Results HERCULES, Calif.—April 30, 2026 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. Norman Schwartz, Bio-Rad's Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds includi ...
Piedmont Office Realty Trust(PDM) - 2026 Q1 - Quarterly Report
2026-05-01 04:17
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________ _______________________________________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the Quarterly Period Ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the Transition Period From ...
Eastman(EMN) - 2026 Q1 - Quarterly Results
2026-05-01 04:17
Exhibit 99.01 Eastman Announces First-Quarter 2026 Financial Results KINGSPORT, Tenn., April 30, 2026 – Eastman Chemical Company (NYSE:EMN) announced its first- quarter 2026 financial results. | (In millions, | | except | per share | | amounts; unaudited) | 1Q2026 | 1Q2025 | | --- | --- | --- | --- | --- | --- | --- | --- | | Sales | revenue | | | | | $2,177 | $2,290 | | Earnings | | before | interest | and | taxes ("EBIT") | 188 | 302 | | Adjusted | | EBIT* | | | | 200 | 311 | | Earnings | per | diluted | ...
Oruka Therapeutics, Inc.(ORKA) - 2026 Q1 - Quarterly Results
2026-05-01 04:17
Exhibit 1.1 Oruka Therapeutics, Inc. (a Delaware Corporation) 9,660,000 Shares of Common Stock UNDERWRITING AGREEMENT April 28, 2026 Leerink Partners LLC TD Securities (USA) LLC Goldman Sachs & Co. LLC Stifel, Nicolaus & Company, Incorporated Guggenheim Securities, LLC as Representatives of the several Underwriters c/o Leerink Partners LLC One Federal Street, 37th Floor Boston, Massachusetts 02110 c/o TD Securities (USA) LLC 1 Vanderbilt Avenue New York, New York 10017 c/o Goldman Sachs & Co. LLC 200 West S ...
ARCA biopharma(ABIO) - 2026 Q1 - Quarterly Results
2026-05-01 04:17
Exhibit 1.1 Oruka Therapeutics, Inc. (a Delaware Corporation) 9,660,000 Shares of Common Stock UNDERWRITING AGREEMENT April 28, 2026 Leerink Partners LLC TD Securities (USA) LLC Goldman Sachs & Co. LLC Stifel, Nicolaus & Company, Incorporated Guggenheim Securities, LLC as Representatives of the several Underwriters c/o Leerink Partners LLC One Federal Street, 37th Floor Boston, Massachusetts 02110 c/o TD Securities (USA) LLC 1 Vanderbilt Avenue New York, New York 10017 c/o Goldman Sachs & Co. LLC 200 West S ...
SPS(SPSC) - 2026 Q1 - Quarterly Results
2026-05-01 04:17
Exhibit 99.1 Contact: Investor Relations The Blueshirt Group Irmina Blaszczyk SPSC@blueshirtgroup.com SPS Commerce Reports First Quarter 2026 Financial Results First quarter 2026 revenue grew 6% and recurring revenue grew 7% from the first quarter of 2025 MINNEAPOLIS, April 30, 2026 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), the leading intelligent supply chain network, today announced financial results for the first quarter ended March 31, 2026. Financial Highlights First Quarter 2026 Financial ...
Evolution Petroleum Schedules Fiscal Third Quarter 2026 Earnings Release and Conference Call
Globenewswire· 2026-05-01 04:17
HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Evolution Petroleum Corporation (NYSE American: EPM) ("Evolution" or the "Company") today announced that it plans to release its fiscal third quarter 2026 financial and operating results on Tuesday, May 12, 2026, after the market closes. Additionally, Kelly Loyd, President and Chief Executive Officer, Ryan Stash, Senior Vice President, Chief Financial Officer, and Treasurer, and Mark Bunch, Chief Operating Officer, will review the results on a conference call at 1 ...